To examine the relationship between TS overexpression and somatic mutations in non-PanNET samples, we analyzed TS expression in patients with 5 different tumor subtypes: prostate, pancreatic, lung adenocarcinoma, lung squamous carcinoma, and cutaneous melanoma, using data collected from The Cancer Genome Atlas (48) and the Clinical Proteomic Tumor Analysis Consortium. This evidence concerns the gene TYMS and neoplasm.